ALFREDO FLORES: Open Payments
NPI 1750913810 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 54 payments from 11 companies in 2025. Trend: 2023 $649 · 2024 $621 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 27 | $596 |
| ViiV Healthcare Company | 9 | $240 |
| Merck Sharp & Dohme LLC | 4 | $105 |
| ABBVIE INC. | 3 | $56 |
| Napo Pharmaceuticals Inc | 3 | $51 |
| Novo Nordisk Inc | 2 | $39 |
| EMD Serono, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Theratechnologies Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: PIFELTRO, CABENUVA, Biktarvy, RUKOBIA, APRETUDE, Mytesi, Yeztugo, MAVYRET.
Industry payments across AZ — which companies pay providers there.
